QS-21

CAT:
804-HY-101092A
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
QS-21 - image 1

QS-21

  • Description:

    QS-21 is a mixture of QS-21-Xyl (HY-101092B) and QS-21-Api (HY-101092), with a ratio of 35:65. QS-21 is an innate immune system-targeted adjuvant. QS-21 is promising for research of oncology vaccines (e.g., melanoma) and infectious disease vaccines (e.g., HIV, malaria) [1].
  • UNSPSC:

    12352005
  • Target:

    Toll-like Receptor (TLR)
  • Related Pathways:

    Immunology/Inflammation
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Cancer; Infection
  • Smiles:

    O[C@H]1COC[C@@H] (O) [C@@H]1O.O[C@H]2COC[C@]2 (O) CO.O[C@H] ([C@@H] ([C@H] ([C@@H] (O3) C) O[C@H]4[C@@H] ([C@H] ([C@@H] (CO4) O) O[R]) O) O) [C@@H]3O[C@H] ([C@H] ([C@H] ([C@H] (O5) C) OC (C[C@@H] (O) C[C@H] (OC (C[C@@H] (O) C[C@@H] ([C@@H] (C) CC) O[C@@H]6O[C@H] ([C@@H] ([C@H]6O) O) CO) =O) [C@H] (CC) C) =O) O) [C@@H]5OC ([C@]78[C@] (CC (C) (CC8) C) ([H]) C9=CC[C@@] ([C@@]%10 ([C@@] ([C@@] (C) ([C@H] (CC%10) O[C@H]%11[C@@H] ([C@H] ([C@@H] ([C@H] (O%11) C (O) =O) O) O[C@H]%12[C@@H] ([C@H] ([C@@H] (CO%12) O) O) O) O[C@@H]%13O[C@@H] ([C@@H] ([C@@H] ([C@H]%13O) O) O) CO) C=O) ([H]) CC%14) C) ([H]) [C@]%14 (C) [C@@]9 (C[C@H]7O) C) =O.[35%].[65%]
  • Molecular Formula:

    C92H148O46
  • Molecular Weight:

    1990.14
  • References & Citations:

    [1]Deng K, et al. Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine. Angew Chem Int Ed Engl. 2008;47 (34) :6395-8.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Natural Products
  • Clinical Information:

    No Development Reported